Comparison of the efficacy of subcutaneous and nasal spray Buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancer
- 1 July 1986
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 46 (1), 104-110
- https://doi.org/10.1016/s0015-0282(16)49466-5
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Pharmacokinetics of Gonadotropin-Releasing Hormone and Its AnalogsEndocrine Reviews, 1986
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.BMJ, 1984
- Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.JCI Insight, 1983
- Absence of gonadotropin-releasing hormone receptors in human gonadal tissueNature, 1982
- Direct inhibition of testicular function by gonadotropin-releasing hormone: mediation by specific gonadotropin-releasing hormone receptors in interstitial cells.Proceedings of the National Academy of Sciences, 1980
- Effect of an LHRH Agonist and hCG on Testicular Steroidogenesis in the Adult RatBiology of Reproduction, 1980
- Extra-pituitary inhibition of testicular function by luteinising hormone releasing hormoneNature, 1979
- Suppression of human spermatogenesis by depot androgen: Potential for male contraceptionJournal of Steroid Biochemistry, 1979
- LH and FSH responses to luteinizing-releasing hormone in normal, adult, human malesMetabolism, 1976